PureTech Health plc (PRTC)

R&D Expense Growth

26.70%

Quarterly · Period ending:

PRTC logo

PRTC R&D Expense Growth

Latest reported26.70%
PRTC Quarterly R&D Growth (QoQ) (0.00% → 26.70%)
High-resolution chart · PNG

PRTC r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

PureTech Health plc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
26.6998%
62.1939%
-60.5631%
-8.9331%
-19.5676%
-25.3314%
-15.8469%
34.8534%
29.7728%
12.8472%
-44.0159%
87.1184%
-9.8178%
2.6957%
32.732%
-8.3322%
2.5148%
36.687%
69.0851%
24.5567%
83.3557%
101.0495%
72.3514%
36.6525%
0%
-33.018%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.